Pioneers in the pharmaceutical industry quickly understood the medical benefits of parenteral drug delivery. Decades worth of evolving systems that promised to optimize and fine-tune efficacy, safety, and patient comfort precede today’s on-body-delivery systems. And as the industry continues to move the needle forward to meet even higher expectations while adhering to increasingly intricate and strict standard requirements, collaborative efforts from testing equipment manufacturers remain essential.

From the early invention of glass syringes in the 1940s to the introduction of autoinjector technology for military use in the 1970s—subsequently leading to the creation of the EpiPen—needle-based drug delivery has been evolving to provide easy-to-administer and pain-minimizing results for patients. This evolution has included both an increasing number of patient indications as well as a growing level of patient usage compliance. In fact, autoinjector usage rates have steadily risen at over 20% per year for the last few decades.